AVNS - Avanos Medical, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.29B
Enterprise Value 31.31B
Trailing P/E N/A
Forward P/E 119.44
PEG Ratio (5 yr expected) 11.52
Price/Sales (ttm)1.85
Price/Book (mrq)1.02
Enterprise Value/Revenue 31.88
Enterprise Value/EBITDA 6-354.51

Trading Information

Stock Price History

Beta (5Y Monthly) 1.18
52-Week Change 3-41.91%
S&P500 52-Week Change 3-11.36%
52 Week High 348.07
52 Week Low 319.46
50-Day Moving Average 328.87
200-Day Moving Average 333.58

Share Statistics

Avg Vol (3 month) 3422.91k
Avg Vol (10 day) 3558.12k
Shares Outstanding 547.76M
Float 47.07M
% Held by Insiders 11.37%
% Held by Institutions 197.43%
Shares Short (Mar 12, 2020) 43.1M
Short Ratio (Mar 12, 2020) 46.82
Short % of Float (Mar 12, 2020) 47.46%
Short % of Shares Outstanding (Mar 12, 2020) 46.50%
Shares Short (prior month Feb 13, 2020) 42.91M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin -6.58%
Operating Margin (ttm)-5.82%

Management Effectiveness

Return on Assets (ttm)-1.40%
Return on Equity (ttm)-3.58%

Income Statement

Revenue (ttm)697.6M
Revenue Per Share (ttm)14.65
Quarterly Revenue Growth (yoy)11.70%
Gross Profit (ttm)402.2M
EBITDA -3.7M
Net Income Avi to Common (ttm)-45.9M
Diluted EPS (ttm)-0.96
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)205.3M
Total Cash Per Share (mrq)4.32
Total Debt (mrq)325.4M
Total Debt/Equity (mrq)25.72
Current Ratio (mrq)2.53
Book Value Per Share (mrq)26.62

Cash Flow Statement

Operating Cash Flow (ttm)-74.5M
Levered Free Cash Flow (ttm)-108.55M